Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...

REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development ...

Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

BioRay Pharmaceutical Co., Ltd. ("BioRay") announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed Class 1 innovative ...

Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...

Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

From research to 'route of administration' to recovery, when it comes to illicit substances, a little planning goes a long ...

Request To Download Free Sample of This Strategic Report @ Introduction: The hypertension drugs market in Vietnam has witnessed significant growth in recent years, owing to the rising prevalence of ...

Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally represents a ...

In dozens of cities, including Milwaukee, the recent rise of fentanyl has put older Black men in particular jeopardy.